STS
BMY icon

SG Trading Solutions’s Bristol-Myers Squibb BMY Stock Holding History

SG Trading Solutions’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.59M Buy
+29,494
New +$1.42M 0.37% 60

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SG Trading Solutions's BMY Position: Q4 2025 in Review

SG Trading Solutions opened a new position in Bristol-Myers Squibb (BMY) in Q4 2025: 29,494 shares worth $1.59M. The stake represents 0.37% of the portfolio and ranks #60 among its holdings.

2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • SG Trading Solutions held 29,494 shares of Bristol-Myers Squibb worth $1.59M as of Q4 2025.
  • Bristol-Myers Squibb was a new SG Trading Solutions position in Q4 2025.
  • Bristol-Myers Squibb made up 0.37% of SG Trading Solutions's portfolio in Q4 2025, its #60 holding.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on SG Trading Solutions's 13F filing for Q4 2025, filed 24 Feb 2026.